The Critical Medicines Act will change how EU public buyers tender for critical medicines. Resilience requirements become mandatory; where a medicine depends heavily on a few non-EU countries, EU-made product and active substance can earn preference; and five or more Member States can ask the European Commission to buy for them. This briefing covers what

Pharmaceutical supplier qualification is not a low price plus a PDF licence. For procurement and quality teams, the lasting question is how to prove, before the first order, that a partner is authorised, that the stock has a traceable history, and that the offer itself carries no signs of falsification. This briefing covers authorisation checks,

Cold chain pharmaceutical shipping fails when buyers treat “we have a fridge truck” as proof of control. For procurement, quality, and logistics teams, the lasting question is what to demand before a temperature-sensitive SKU moves: lane and packaging qualification, temperature data, excursion handling, handovers, carrier capability, documentation, and contingency. This briefing translates those demands into

Shortage resilient pharmaceutical sourcing starts with a hard truth: drug shortages rarely begin at the loading dock. Quality holds, contamination events, and sole-facility or sole-country upstream dependencies usually surface months before a purchase order fails. This briefing maps those patterns for procurement, pharmacy operations, and quality–logistics leads — and closes with a lasting checklist for